The inhibitory effect of Sulindac on human pancreatic cancer cells' proliferation by targeting survivin/ Aurora B pathway
- VernacularTitle:舒林酸经survivin/Aurora B途径对人胰腺癌细胞分裂的阻断效应
- Author:
Xueke FAN
;
Yusheng LIAO
;
Cuifang ZHANG
;
Fen CHEN
;
Huitao GAO
;
Hua QIN
;
Demin LI
;
Qiu ZHAO
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Sulindac;
Cell cycle;
Survivin;
Aurora B;
Chromosomal passenger complex
- From:
Chinese Journal of Pancreatology
2008;8(5):315-318
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the expression of survivin and Aurora B in human pancreatic cancer BXPC3 cells after the treatment of sulindac and to explore the potential mechanism. Methods MTr assay was used to determine the effect of sulindac on the proliferation of the BXPC3 cells. RT-PCR was used to detect the expression of mRNA level of survivin and Aurora B, western blot was used to detect protein expression of survivin and Aurora B Thr-232. Cell cycle and apoptosis were detected by flow eytometry (FCM). Results The BXPC3 cells were inhibited by sulindac in a dose and time-dependent manner; the expression of mRNA of survivin and Aurora B were both significantly decreased from 1.5644 and 0.6554 to 0. 4372 and 0.1132 (P< 0.01), the expression of survivin protein and the phosphorylation of Aurora B Thr-232 were also decreased from 1.2735 and 0.4680 to 0.2126 and 0.2546 (P<0.01); the proportion of cells in the G0/G1 phase was increased from (56.65±1.93)% to (70.58±3.21)% (P<0.01). Conclusions Sulindac had inhibitory effects on the growth of BXPC3 cells, the possible mechanism was via decreasing the expression of survivin which depressed the activity of Aurora B, then the CPC was influenced. The most of the cells were blocked in the G0/G1 phase, and the cells' mitosis was inhibited.
